vs
Side-by-side financial comparison of Edible Garden AG Inc (EDBL) and Relay Therapeutics, Inc. (RLAY). Click either name above to swap in a different company.
Relay Therapeutics, Inc. is the larger business by last-quarter revenue ($7.0M vs $4.1M, roughly 1.7× Edible Garden AG Inc). Edible Garden AG Inc produced more free cash flow last quarter ($-2.8M vs $-235.9M).
Edible Garden AG Inc is a U.S.-based sustainable agricultural company specializing in hydroponically grown fresh organic herbs, leafy greens, and specialty vegetables. It distributes its pesticide-free produce to leading grocery retailers, food service operators, and direct-to-consumer platforms across North America, prioritizing eco-friendly, low-water farming practices.
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
EDBL vs RLAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.1M | $7.0M |
| Net Profit | — | — |
| Gross Margin | -29.0% | — |
| Operating Margin | -138.6% | — |
| Net Margin | — | — |
| Revenue YoY | 6.6% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $-109.97 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.1M | $7.0M | ||
| Q3 25 | $2.8M | $0 | ||
| Q2 25 | $3.1M | — | ||
| Q1 25 | $2.7M | $7.7M | ||
| Q4 24 | $3.9M | $0 | ||
| Q3 24 | $2.6M | $0 | ||
| Q2 24 | $4.3M | $0 | ||
| Q1 24 | $3.1M | $10.0M |
| Q4 25 | — | — | ||
| Q3 25 | $-4.0M | $-74.1M | ||
| Q2 25 | $-4.0M | — | ||
| Q1 25 | $-3.3M | $-77.1M | ||
| Q4 24 | $-3.1M | — | ||
| Q3 24 | $-2.1M | $-88.1M | ||
| Q2 24 | $-1.9M | $-92.2M | ||
| Q1 24 | $-4.0M | $-81.4M |
| Q4 25 | -29.0% | — | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | 20.2% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 36.7% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | -138.6% | — | ||
| Q3 25 | -126.3% | — | ||
| Q2 25 | -114.2% | — | ||
| Q1 25 | -107.7% | -1105.2% | ||
| Q4 24 | -70.8% | — | ||
| Q3 24 | -57.7% | — | ||
| Q2 24 | -27.7% | — | ||
| Q1 24 | -123.3% | -903.0% |
| Q4 25 | — | — | ||
| Q3 25 | -143.6% | — | ||
| Q2 25 | -128.5% | — | ||
| Q1 25 | -122.3% | -1003.6% | ||
| Q4 24 | -79.5% | — | ||
| Q3 24 | -79.8% | — | ||
| Q2 24 | -45.3% | — | ||
| Q1 24 | -127.0% | -813.3% |
| Q4 25 | $-109.97 | — | ||
| Q3 25 | $1.38 | $-0.43 | ||
| Q2 25 | $-6.58 | — | ||
| Q1 25 | $-2.47 | $-0.46 | ||
| Q4 24 | $-330.78 | — | ||
| Q3 24 | $16.32 | $-0.63 | ||
| Q2 24 | $-30.02 | $-0.69 | ||
| Q1 24 | $-341.14 | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.0M |
| Total DebtLower is stronger | $1.7M | — |
| Stockholders' EquityBook value | $12.5M | $567.1M |
| Total Assets | $20.6M | $621.3M |
| Debt / EquityLower = less leverage | 0.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $91.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $93.5M | ||
| Q4 24 | — | $124.3M | ||
| Q3 24 | — | $152.4M | ||
| Q2 24 | — | $134.1M | ||
| Q1 24 | — | $152.9M |
| Q4 25 | $1.7M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $12.5M | $567.1M | ||
| Q3 25 | $12.9M | $607.7M | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $1.9M | $721.1M | ||
| Q4 24 | $4.1M | $777.8M | ||
| Q3 24 | $3.3M | $838.9M | ||
| Q2 24 | $511.0K | $681.7M | ||
| Q1 24 | $-4.1M | $745.8M |
| Q4 25 | $20.6M | $621.3M | ||
| Q3 25 | $20.1M | $670.0M | ||
| Q2 25 | $21.8M | — | ||
| Q1 25 | $8.5M | $799.4M | ||
| Q4 24 | $11.9M | $871.3M | ||
| Q3 24 | $8.9M | $930.1M | ||
| Q2 24 | $9.9M | $772.5M | ||
| Q1 24 | $6.3M | $841.4M |
| Q4 25 | 0.13× | — | ||
| Q3 25 | 0.21× | — | ||
| Q2 25 | 1.28× | — | ||
| Q1 25 | 1.24× | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | $-235.5M |
| Free Cash FlowOCF − Capex | $-2.8M | $-235.9M |
| FCF MarginFCF / Revenue | -66.8% | -3370.0% |
| Capex IntensityCapex / Revenue | 2.3% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.4M | $-622.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.7M | $-235.5M | ||
| Q3 25 | $-2.4M | $-62.1M | ||
| Q2 25 | $-3.4M | — | ||
| Q1 25 | $-3.3M | $-73.2M | ||
| Q4 24 | $-1.8M | $-249.1M | ||
| Q3 24 | $-1.1M | $-75.1M | ||
| Q2 24 | $-4.6M | $-65.8M | ||
| Q1 24 | $-1.1M | $-50.3M |
| Q4 25 | $-2.8M | $-235.9M | ||
| Q3 25 | $-2.8M | $-62.1M | ||
| Q2 25 | $-3.5M | — | ||
| Q1 25 | $-3.4M | $-73.6M | ||
| Q4 24 | $-1.9M | $-251.1M | ||
| Q3 24 | $-1.1M | $-75.3M | ||
| Q2 24 | $-4.7M | $-65.8M | ||
| Q1 24 | $-1.1M | $-52.1M |
| Q4 25 | -66.8% | -3370.0% | ||
| Q3 25 | -98.9% | — | ||
| Q2 25 | -110.8% | — | ||
| Q1 25 | -125.5% | -958.4% | ||
| Q4 24 | -48.6% | — | ||
| Q3 24 | -43.4% | — | ||
| Q2 24 | -110.2% | — | ||
| Q1 24 | -35.6% | -520.7% |
| Q4 25 | 2.3% | 5.9% | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 2.9% | 5.0% | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 1.8% | 17.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EDBL
| Herbs Produce Floral | $3.6M | 86% |
| Other | $576.0K | 14% |
RLAY
Segment breakdown not available.
